XWELL Inc. (XWEL) - Net Assets
Based on the latest financial reports, XWELL Inc. (XWEL) has net assets worth $-12.58 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.22 Million) and total liabilities ($23.80 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check XWEL asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-12.58 Million |
| % of Total Assets | -112.15% |
| Annual Growth Rate | N/A |
| 5-Year Change | -112.59% |
| 10-Year Change | -119.6% |
| Growth Volatility | 79.52 |
XWELL Inc. - Net Assets Trend (2008–2025)
This chart illustrates how XWELL Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of XWELL Inc. for the complete picture of this company's asset base.
Annual Net Assets for XWELL Inc. (2008–2025)
The table below shows the annual net assets of XWELL Inc. from 2008 to 2025. For live valuation and market cap data, see how much is XWELL Inc. worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-12.58 Million | -262.49% |
| 2024-12-31 | $7.74 Million | -63.08% |
| 2023-12-31 | $20.97 Million | -56.26% |
| 2022-12-31 | $47.95 Million | -52.02% |
| 2021-12-31 | $99.94 Million | +24.34% |
| 2020-12-31 | $80.37 Million | +3269.20% |
| 2019-12-31 | $-2.54 Million | -119.31% |
| 2018-12-31 | $13.13 Million | -71.35% |
| 2017-12-31 | $45.84 Million | -28.57% |
| 2016-12-31 | $64.17 Million | +58.38% |
| 2015-12-31 | $40.52 Million | +29.94% |
| 2014-12-31 | $31.18 Million | -72.72% |
| 2013-12-31 | $114.28 Million | -22.96% |
| 2012-12-31 | $148.33 Million | +12832.36% |
| 2011-12-31 | $-1.17 Million | -387.45% |
| 2010-12-31 | $-239.00K | +98.54% |
| 2009-12-31 | $-16.38 Million | -49.30% |
| 2008-12-31 | $-10.97 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to XWELL Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 47572100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $61.00K | % |
| Other Comprehensive Income | $-1.54 Million | % |
| Other Components | $469.14 Million | % |
| Total Equity | $-22.04 Million | 100.00% |
XWELL Inc. Competitors by Market Cap
The table below lists competitors of XWELL Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Elaia Investment Spain Socimi SA
MC:YEIS
|
$10.15 Million |
|
Trailbreaker Resources Ltd
V:TBK
|
$10.15 Million |
|
PATERSON RESOURCES LTD
F:U40
|
$10.16 Million |
|
Allied Gaming & Entertainment Inc.
NASDAQ:AGAE
|
$10.16 Million |
|
Logismos Information Systems S.A
AT:LOGISMOS
|
$10.14 Million |
|
Peregrine Gold Ltd
AU:PGD
|
$10.14 Million |
|
Puri Global Sukses Tbk Pt
JK:PURI
|
$10.14 Million |
|
GlycoMimetics Inc
NASDAQ:GLYC
|
$10.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in XWELL Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -788,000 to -22,038,000, a change of -21,250,000.
- Net loss of 16,991,000 reduced equity.
- Dividend payments of 267,000 reduced retained earnings.
- Share repurchases of 1,794,000 reduced equity.
- New share issuances of 3,745,000 increased equity.
- Other comprehensive income increased equity by 418,000.
- Other factors decreased equity by 6,361,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-16.99 Million | -77.1% |
| Dividends Paid | $267.00K | -1.21% |
| Share Repurchases | $1.79 Million | -8.14% |
| Share Issuances | $3.75 Million | +16.99% |
| Other Comprehensive Income | $418.00K | +1.9% |
| Other Changes | $-6.36 Million | -28.86% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares XWELL Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $-10497.61 | $1.28 | x |
| 2009-12-31 | $-6.85 | $1.28 | x |
| 2010-12-31 | $-531.11 | $1.28 | x |
| 2011-12-31 | $-1405.31 | $1.28 | x |
| 2012-12-31 | $42722.35 | $1.28 | x |
| 2013-12-31 | $16467.15 | $1.28 | x |
| 2014-12-31 | $4135.28 | $1.28 | x |
| 2015-12-31 | $4758.75 | $1.28 | x |
| 2016-12-31 | $4709.87 | $1.28 | x |
| 2017-12-31 | $2201.32 | $1.28 | x |
| 2018-12-31 | $375.86 | $1.28 | x |
| 2019-12-31 | $-76.34 | $1.28 | x |
| 2020-12-31 | $34.92 | $1.28 | x |
| 2021-12-31 | $17.65 | $1.28 | x |
| 2022-12-31 | $8.53 | $1.28 | x |
| 2023-12-31 | $3.11 | $1.28 | x |
| 2024-12-31 | $-0.17 | $1.28 | x |
| 2025-12-31 | $-3.96 | $1.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently XWELL Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -58.17%
- • Asset Turnover: 2.60x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-75.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.24 Million |
| 2009 | 0.00% | -30745.00% | 0.01x | 0.00x | $-4.51 Million |
| 2010 | 0.00% | -4711.85% | 0.04x | 0.00x | $-9.92 Million |
| 2011 | 0.00% | -1041.64% | 0.38x | 0.00x | $-7.36 Million |
| 2012 | -14.05% | -5647.97% | 0.00x | 1.06x | $-35.67 Million |
| 2013 | -45.88% | -4766.64% | 0.01x | 1.08x | $-63.86 Million |
| 2014 | -351.75% | -7696.63% | 0.04x | 1.20x | $-112.80 Million |
| 2015 | -27.54% | -49.18% | 0.45x | 1.25x | $-15.21 Million |
| 2016 | -40.33% | -126.52% | 0.23x | 1.39x | $-29.96 Million |
| 2017 | -70.54% | -59.07% | 0.75x | 1.60x | $-32.93 Million |
| 2018 | -408.58% | -74.27% | 1.64x | 3.36x | $-38.12 Million |
| 2019 | 0.00% | -43.75% | 1.69x | 0.00x | $-20.60 Million |
| 2020 | -116.30% | -1079.17% | 0.08x | 1.33x | $-98.27 Million |
| 2021 | 3.61% | 4.54% | 0.58x | 1.37x | $-5.92 Million |
| 2022 | -82.24% | -58.70% | 0.79x | 1.76x | $-36.83 Million |
| 2023 | -213.36% | -92.14% | 0.77x | 3.00x | $-29.04 Million |
| 2024 | 0.00% | -49.72% | 1.34x | 0.00x | $-16.77 Million |
| 2025 | 0.00% | -58.17% | 2.60x | 0.00x | $-14.79 Million |
Industry Comparison
This section compares XWELL Inc.'s net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $694,923,903
- Average return on equity (ROE) among peers: -98.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| XWELL Inc. (XWEL) | $-12.58 Million | 0.00% | N/A | $10.15 Million |
| Agilent Technologies Inc (A) | $5.90 Billion | 21.85% | 1.01x | $32.42 Billion |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.49 Million | -115.35% | 0.92x | $7.19 Million |
| Applied DNA Sciences Inc (APDN) | $5.71 Million | -223.57% | 0.99x | $3.99 Million |
| Biodesix Inc (BDSX) | $-228.54 Million | 0.00% | 0.00x | $79.44 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $9.85 Million |
| Biocept Inc. (BIOCQ) | $11.20 Million | -224.43% | 0.58x | $262.00 |
| BillionToOne, Inc. Class A Common Stock (BLLN) | $30.47 Million | -271.32% | 5.29x | $3.21 Billion |
| Burning Rock Biotech Ltd (BNR) | $768.41 Million | -85.07% | 0.35x | $154.44 Million |
| CareDx Inc (CDNA) | $465.88 Million | -6.58% | 0.22x | $1.00 Billion |
| Check Cap Ltd (CHEK) | $10.41 Million | -84.81% | 0.18x | $9.42 Million |
About XWELL Inc.
XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport empl… Read more